CVAT Cavitation Technologies, Inc.
Agricultural Services · OTC · SEC CIK 1376793 · Fiscal year ends 06/30
Financial factors as of 2026-06-30 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-98.5%
TTM net income YoY-1,142.5%
TTM EPS YoY—
Revenue 3-yr CAGR-80.6%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-46,266.7%
Net margin-46,800.0%
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-821.1%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets1,640.0%
Debt / equity—
Current ratio0.06x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.54x
Accruals ratio-379.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-09-30 | 2026Q4*2026-06-30 | 2026Q32026-03-31 | 2026Q22025-12-31 | 2026Q12025-09-30 | 2025Q4*2025-06-30 | 2025Q32025-03-31 | 2025Q22024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $0 | -$3,000 | $3,000 | $0 | $3,000 | $5,000 | $122,000 | $76,000 |
| Cost of revenue | — | $0 | $0 | $0 | — | $0 | $25,000 | $13,000 |
| Gross profit | — | -$3,000 | $3,000 | $0 | — | $5,000 | $97,000 | $63,000 |
| R&D expense | $0 | $0 | $0 | $4,000 | $7,000 | $29,000 | $42,000 | $16,000 |
| SG&A expense | $165,000 | $431,000 | $234,000 | $470,000 | $245,000 | $210,000 | $283,000 | $346,000 |
| Operating income | -$165,000 | -$434,000 | -$231,000 | -$474,000 | -$249,000 | -$234,000 | -$228,000 | -$299,000 |
| Interest expense | — | — | $3,000 | $2,000 | $9,000 | $1,000 | $2,000 | $2,000 |
| Net income | -$208,000 | -$451,000 | -$219,000 | -$476,000 | -$258,000 | -$235,000 | -$230,000 | $579,000 |
| EBITDA | — | — | — | — | — | -$234,000 | -$228,000 | — |
| EPS (basic) | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
| EPS (diluted) | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 319.23M | — | 309.72M | 301.18M | 289.16M | — | 286.47M | 284.29M |
| Balance sheet | ||||||||
| Cash & equivalents | $94,000 | $17,000 | $45,000 | $31,000 | $30,000 | $249,000 | $432,000 | $681,000 |
| Receivables | $0 | $0 | $3,000 | $0 | $5,000 | $10,000 | $122,000 | — |
| Inventory | — | — | — | — | — | — | — | $11,000 |
| Current assets | $107,000 | $34,000 | $55,000 | $44,000 | $49,000 | $286,000 | $565,000 | $701,000 |
| Total assets | $118,000 | $45,000 | $66,000 | $55,000 | $60,000 | $297,000 | $576,000 | $718,000 |
| Current liabilities | $707,000 | $588,000 | $383,000 | $153,000 | $99,000 | $78,000 | $150,000 | $613,000 |
| Long-term debt | $150,000 | $150,000 | $150,000 | $150,000 | $150,000 | $150,000 | $127,000 | $128,000 |
| Total debt | $150,000 | $150,000 | $150,000 | $150,000 | $150,000 | $150,000 | $127,000 | $128,000 |
| Total liabilities | $857,000 | $738,000 | $533,000 | $303,000 | $249,000 | $228,000 | $277,000 | $741,000 |
| Shareholders' equity | -$739,000 | -$693,000 | -$467,000 | -$248,000 | -$189,000 | $69,000 | $299,000 | -$23,000 |
| Net debt | $56,000 | $133,000 | $105,000 | $119,000 | $120,000 | -$99,000 | -$305,000 | -$553,000 |
| Shares outstanding | 324.32M | 317.22M | 309.72M | 309.72M | 289.16M | 289.16M | 288.96M | 284.29M |
| Cash flow statement | ||||||||
| Operating cash flow | -$128,000 | -$228,000 | -$126,000 | -$182,000 | -$219,000 | -$182,000 | -$248,000 | -$201,000 |
| Investing cash flow | — | $0 | $0 | — | — | $0 | $0 | — |
| Financing cash flow | $205,000 | $200,000 | $140,000 | $183,000 | $0 | -$1,000 | -$1,000 | $0 |
| Depreciation & amortization | — | — | — | — | — | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 65 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.